Welcome to the MD Analytics Panel!
You have joined an exclusive group of Canadian healthcare professionals, who wish to participate in market research.
This is what you can expect as a member of our panel:
- You will receive invitations by email to participate in market research studies that are relevant to your profession. (Please add email@example.com to your safe sender list.)
- The survey invitation will always clearly communicate to you the format of the study you are being invited to participate in, estimated length of the study, and the incentive amount.
- As our studies often fill quickly, we urge you to participate as soon as you can.
We do our very best to ensure that the studies we send your way are pertinent to your practice. Keeping your profile up to date will help us better identify studies that are most relevant to you.
All studies that we conduct contain a set of screening questions at the beginning of the study. To learn more about why these are necessary, please read our post on the importance of screeners.
At any time, should you have questions or require support with a study, please contact us and one of our team members will help you.
We look forward to your participation.
Latest Survey Data
Market research plays a fundamental role in helping those involved in the healthcare market answer key questions about their brands. Gaining insights from healthcare practitioners is central to market research. However, engaging physicians to participate in research can be a challenge. While most of the surveyed physicians say they enjoy participating in market research studies, in practice, physicians self-report participating in less than half of the number of studies they are invited to participate in. Real-world experience from our panel says the response rate is even lower. With this in mind, we asked Canadian physicians to help us understand what motivates them to do market research.
Engaging prescribers is a key component to the launch of any new brand. But what are the key components that drive interest for physicians in learning more?
Overall, physicians express greater satisfaction when learning about new products through in person interactions compared to virtual or digital interactions. However, regardless of how they learn about new product, the types of resources physicians prefer are similar. The top most preferred resources for both GPs and Specialists include presentation at conferences, discussions with peers, educational events that include KOLs or treatment areas experts, presentations by lead authors, journal clubs and discussions with Pharmaceutical reps. While a majority agree (66%) they are more likely to engage with reps or MSLs to discuss new products or indications, more physicians agree (87%) they are more likely to meet with a rep or MSL with whom they have an established relationship.
The COVID-19 pandemic had a significant impact on physicians, including how they learn about and integrate new products into their practice. While not all saw a decline, close to 1 in 3 Specialists and close to half of GPs say their use of newly launched products declined during the pandemic, primarily due to a lack of pharma presence, reduced patient volumes overall and just a general lack of comfort using new products.